Top Markets
Coin of the day
Bonesupport Holding AB (publ) Bonesupport Holding AB (publ)

Bonesupport Holding AB (publ)

BONEX
株式のランク #7234
Bonesupport Holding AB (publ) is an orthobiologics company that specializes in... Bonesupport Holding AB (publ) is an orthobiologics company that specializes in the development and commercialization of injectable bioceramic bone graft substitutes. These products are utilized for treating bone voids and are available internationally, including in Europe and North America. Among its key offerings are CERAMENT Bone Void Filler, a synthetic, injectable, moldable, and drillable solution comprising hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol. Additionally, the company provides CERAMENT G, an injectable ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic bone void filler containing vancomycin. Bonesupport is also advancing preclinical product candidates focused on promoting bone regrowth. These future solutions are being developed for applications such as trauma, revision arthroplasty, chronic osteomyelitis, oncology, and bone and foot infections related to diabetes. Founded in 1999, the company maintains its headquarters in Lund, Sweden.
株価
$25.44
最終同期: 2026-08-27
時価総額
$1.67B
変化(1日)
-0.18%
変化(1年)
-22.85%
SE
取引 Bonesupport Holding AB (publ) (BONEX)

カテゴリー

Bonesupport Holding AB (publ)(BONEX)の収益
Aug 2026 時点の収益 TTM: 0
Bonesupport Holding AB (publ) の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Bonesupport Holding AB (publ) の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差
$46.59B -
US
$25.84B -
US
$35.48B -
IE
$21.00B -
US
- -
DE